248 related articles for article (PubMed ID: 26646779)
1. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
[TBL] [Abstract][Full Text] [Related]
2. Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
Otero A; Betancor M; Eraña H; Fernández Borges N; Lucas JJ; Badiola JJ; Castilla J; Bolea R
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466523
[TBL] [Abstract][Full Text] [Related]
3. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
4. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
5. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK
Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750
[TBL] [Abstract][Full Text] [Related]
6. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
7. Misfolded PrP and a novel mechanism of proteasome inhibition.
Andre R; Tabrizi SJ
Prion; 2012; 6(1):32-6. PubMed ID: 22453175
[TBL] [Abstract][Full Text] [Related]
8. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
9. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
[TBL] [Abstract][Full Text] [Related]
10. Prions and the proteasome.
Deriziotis P; Tabrizi SJ
Biochim Biophys Acta; 2008 Dec; 1782(12):713-22. PubMed ID: 18644436
[TBL] [Abstract][Full Text] [Related]
11. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
12. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
13. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
Cheroni C; Marino M; Tortarolo M; Veglianese P; De Biasi S; Fontana E; Zuccarello LV; Maynard CJ; Dantuma NP; Bendotti C
Hum Mol Genet; 2009 Jan; 18(1):82-96. PubMed ID: 18826962
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated prion protein oligomers inhibit the 26S proteasome.
Kristiansen M; Deriziotis P; Dimcheff DE; Jackson GS; Ovaa H; Naumann H; Clarke AR; van Leeuwen FW; Menéndez-Benito V; Dantuma NP; Portis JL; Collinge J; Tabrizi SJ
Mol Cell; 2007 Apr; 26(2):175-88. PubMed ID: 17466621
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury.
Engel T; Martinez-Villarreal J; Henke C; Jimenez-Mateos EM; Sanz-Rodriguez A; Alves M; Hernandez-Santana Y; Brennan GP; Kenny A; Campbell A; Lucas JJ; Henshall DC
Mol Neurodegener; 2017 Feb; 12(1):21. PubMed ID: 28235423
[TBL] [Abstract][Full Text] [Related]
16. Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.
West Greenlee MH; Lind M; Kokemuller R; Mammadova N; Kondru N; Manne S; Smith J; Kanthasamy A; Greenlee J
Am J Pathol; 2016 Sep; 186(9):2302-9. PubMed ID: 27521336
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome system in neurodegeneration.
McKinnon C; Tabrizi SJ
Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
[TBL] [Abstract][Full Text] [Related]
18. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
[TBL] [Abstract][Full Text] [Related]
19. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.
Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N
Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
